Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

As of June 30, 2022, Series A and Series B preferred shares reflected on the balance sheet is reconciled on the following table (in thousands): (Details)

As of June 30, 2022, Series A and Series B preferred shares reflected on the balance sheet is reconciled on the following table (in thousands): (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Series A Preferred Stock [Member]
Gross Proceeds	$ 23,750
Preferred stock issuance costs	(1,046)
Accretion of carrying value to redemption value	3,546
Preferred stock subject to possible redemption	26,250
Series B Preferred Stock [Member]
Gross Proceeds	4,750
Preferred stock issuance costs	(209)
Accretion of carrying value to redemption value	709
Preferred stock subject to possible redemption	$ 5,250

- Definition

Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.

+ References + Details